Regulatory Focus


Complexity

  • Vaccines Site Investment (Germany / TIC 175 mio euro); concurrent manufacturing, multiple regulatory registrations, complex facility validation

Health, Safety and Environmental protection;

  • As a norm – All activities are executed with HSE as an integrated priority for project and operations as a given; Best in class LTI free performance, HAZOP and sustainability